RHEUM YIR PsA 2019

The prevalence of neuropathic-like pain was found to be high in patients with psoriatic arthritis, a condition that may be associated with higher disease activity and fibromyalgia.

A higher prevalence of NAFLD was observed among patients with psoriasis without arthritis compared with patients with psoriatic arthritis.

Real-life data support the validity of switching from reference etanercept to SB4 for most patients with psoriatic arthritis.

Investigators assessed the risk for herpes zoster and provided recommendations regarding treatment in patients with psoriasis.

Anti-TNF-α agents have the same efficacy as ustekinumab, secukinumab, and ixekizumab in terms of dactylitis and enthesitis resolution.

Elevated C-reactive protein levels at baseline were associated with greater structural progression in psoriatic arthritis.

The presence of psoriatic nail dystrophy was linked to erosive damage at the distal interphalangeal joints.